Engineered Type IV Pilin of Clostridium Difficile

The present invention relates to engineered Clostridium difficile type IV pilin (tfp) genes, type IV pilin proteins which can serve as a diagnostic marker for identification of patients infected with C. difficile, and vaccines comprising type IV pilin proteins, antigenic fragments and variants thereof for therapeutic interventions.

Attached files:
WO 2010135585.jpg

Patents:
WO 2,010,135,585   [MORE INFO]

Inventor(s): DONNENBERG MICHAEL [US]

Type of Offer: Licensing



Next Patent »
« More Biotech Patents

Share on      


CrowdSell Your Patent